Medmix Ltd
SIX:MEDX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.64
19
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Medmix Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | CH |
Market Cap | 352.8m CHF |
Operating Margin |
3%
|
Country | US |
Market Cap | 204.9B USD |
Operating Margin |
17%
|
Country | US |
Market Cap | 195.2B USD |
Operating Margin |
26%
|
Country | US |
Market Cap | 146.7B USD |
Operating Margin |
22%
|
Country | US |
Market Cap | 132.6B USD |
Operating Margin |
18%
|
Country | IE |
Market Cap | 110.6B USD |
Operating Margin |
19%
|
Country | US |
Market Cap | 64.7B USD |
Operating Margin |
14%
|
Country | DE |
Market Cap | 55.6B EUR |
Operating Margin |
12%
|
Country | CN |
Market Cap | 319.2B CNY |
Operating Margin |
37%
|
Country | US |
Market Cap | 41.6B USD |
Operating Margin |
28%
|
Country | US |
Market Cap | 37.7B USD |
Operating Margin |
13%
|
Medmix Ltd
Glance View
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Medmix Ltd's most recent financial statements, the company has Operating Margin of 3.4%.